PROTEASEHEMMUNG

Patent europeic · EP1981519 · En vigur

Inscripziun en il register

Numer da publicaziun
EP1981519
Numer da la dumonda
EP06848187
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
27-12-2006
Publitgà
22-10-2008
Concedì
27-12-2017
La protecziun finescha il pli tard
26-12-2026
Proxima taxa annuala scadenta
31-12-2026
Classas IPC
C07K 14/81 (2006.01)
A61K 38/00 (2006.01)
Prioritad
US 754903 P 29.12.2005
Dumonda PCT
PCT/US2006/049322 27.12.2006
Publicaziun PCT
WO2007/079096 12.07.2007
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-01-2026

    Midada

    Published in Swissreg on 01.01.2026

  2. 01-01-2025

    Midada

    Published in Swissreg on 01.01.2025

  3. 01-01-2024

    Midada

    Published in Swissreg on 01.01.2024

  4. 01-01-2023

    Midada

    Published in Swissreg on 01.01.2023

  5. 29-05-2021

    Transferì

    Owner
    Dyax Corp., 55 Network Drive, Burlington, MA 01803, USA → Takeda Pharmaceutical Company Limited, 1-1, Doshomachi 4-chome, Chuo-ku, Osaka-shi, Osaka, Japan

    Published in Swissreg on 29.05.2021

  6. 27-12-2017

    Concedì

    Published in Swissreg on 27.12.2017

Partidas

Possessur

Takeda Pharmaceutical Company Limited

1-1, Doshomachi 4-chome Chuo-ku, Osaka-shi, Osaka, JP

Inventur

LADNER, Robert C.

Ijamsville, Maryland 21754, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.